Abstract:Objectives Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. Study Design The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Results Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. Conclusions IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP. Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP.

The Tipped Balance of ILC1/ILC2 in Peripheral Blood of Oral Lichen Planus Is Related to Inflammatory Cytokines

Group 1 and 3 Innate Lymphoid Cells Are Increased in Oral Lichen Planus and Oral Lichenoid Lesions.

Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.

Increased Infiltration of CD11 C+/cd123+ Dendritic Cell Subsets and Upregulation of TLR/IFN-α Signaling Participate in Pathogenesis of Oral Lichen Planus.

Characterizing inducible tertiary lymphoid structures in oral lichen planus: implications for stromal-immune cells interaction and disease severity

Overexpressed Interleukin-6 Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus: an in Vitro Study

Inflammation-related Cytokines in Oral Lichen Planus: an Overview.

Increased circulating CXCR5 + CD4 + T follicular helper-like cells in oral lichen planus.

Increasing CCL5/CCR5 on CD4+ T Cells in Peripheral Blood of Oral Lichen Planus

Overexpression and Selectively Regulatory Roles of IL-23/IL-17 Axis in the Lesions of Oral Lichen Planus

Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus

The Activation of NF-κB in Infiltrated Mononuclear Cells Negatively Correlates with Treg Cell Frequency in Oral Lichen Planus

Single-cell immune profiling reveals immune responses in oral lichen planus

ThPOK and Runx3 Regulate the Differentiation of CD4+CD8αα+ IELs in Oral Lichen Planus

Expression of T-bet and GATA-3 in Peripheral Blood Mononuclear Cells of Patients with Oral Lichen Planus.

Role of Distinct CD4(+) T Helper Subset in Pathogenesis of Oral Lichen Planus.

CD4+CD8αα+ is the dominant phenotype of intraepithelial lymphocytes and regulated by ThPOK and Runx3 in Oral lichen planus

Aberrant Activation of the STING-TBK1 Pathway in γδ T Cells Regulates Immune Responses in Oral Lichen Planus

Significance of regulatory T cells in the peripheral blood of oral lichen planus patients

IFN-gamma and IL-4 in Saliva of Patients with Oral Lichen Planus: a Study in an Ethnic Chinese Population.

Increased pathogenicity and pro-inflammatory capabilities of mucosal-associated invariant T cells involved in Oral Lichen Planus